Yan Li

重庆医科大学

H指数:29

被引数:4,051

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model

异常脂质代谢导致MASH模型中T淋巴母细胞淋巴瘤表现出侵袭性行为

Oncogene

IF7.3

2025-11-260

OAAI

Clinical and genetic characteristics of diseases caused by CFTR gene mutations in 15 Chinese children: a retrospective analysis

由CFTR基因突变引起的15例中国儿童疾病的临床与遗传特征：一项回顾性分析

BMC PEDIATRICS

IF2

2025-10-020

OAAI

Cyclic catalysis of intratumor Fe3+/2+ initiated by a hollow mesoporous iron sesquioxide nanoparticle for ferroptosis therapy of large tumors

BIOMATERIALS

IF12.9

2025-02-010

PRE

A strategy of adding fuel to the flames enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy

BIOMATERIALS

IF12.9

2024-12-0112

PRE

Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice

巨噬细胞受损有助于FGF21KO小鼠MASH进展为肝细胞癌

SCIENCE ADVANCES

IF12.5

2024-10-250

OAAI

A hollow mesoporous iron oxide nanoparticle to strengthen Fenton reaction and weaken antioxidant defense systems for high efficacy tumor ferroptosis therapy

CHEMICAL ENGINEERING JOURNAL

IF13.2

2024-10-012

PRE

NIR-II light-powered core-shell prodrug nanomotors enhance cancer therapy through synergistic oxidative stress-photothermo modulation

Nir-ii光动力核壳前药纳米马达通过协同氧化应激-光热调节增强癌症治疗

ACTA BIOMATERIALIA

IF9.6

2024-09-010

PRE

Triggering of endoplasmic reticulum stress via ATF4-SPHK1 signaling promotes glioblastoma invasion and chemoresistance

CELL DEATH & DISEASE

IF9.6

2024-08-011

OAAI

Inhibition of N-acetylglucosaminyltransferase V alleviates diabetic cardiomyopathy in mice by attenuating cardiac hypertrophy and fibrosis

NUTRITION & METABOLISM

IF4.1

2024-07-300

OAAI

Non-alcoholic fatty liver disease promotes breast cancer progression through upregulated hepatic fibroblast growth factor 21

CELL DEATH & DISEASE

IF9.6

2024-01-184

OAAI

From biomaterials to biotherapy: cuttlefish ink with protoporphyrin IX nanoconjugates for synergistic sonodynamic-photothermal therapy

JOURNAL OF MATERIALS CHEMISTRY B

IF5.7

2024-01-013

PRE

Self-Propelled Enzymatic Nanomotors from Prodrug-Skeletal Zeolitic Imidazolate Frameworks for Boosting Multimodel Cancer Therapy Efficiency

来自前药-骨架沸石咪唑酯框架的自推进酶纳米马达，用于提高多模式癌症治疗效率

ADVANCED SCIENCE

IF14.1

2023-05-1518

EPB-53 prevents NASH-HCC transition via regulation of SPHK1-S1P-HIPPO signaling and immune modulation in a murine model

CANCER RESEARCH

IF16.6

2023-04-041

PRE

Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells:: Implications for modulating arteriogenesis and angiogenesis

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27520

OAAI

Second malignant neoplasms in lymphomas, secondary lymphomas and lymphomas in metabolic disorders/diseases

CELL AND BIOSCIENCE

IF6.2

2022-03-124

OAAI

Abnormal Changes of Monocyte Subsets in Patients With Sjogren's Syndrome

FRONTIERS IN IMMUNOLOGY

IF5.9

2022-03-0416

OAAI

The induction of peripheral trained immunity in the pancreas incites anti-tumor activity to control pancreatic cancer progression

NATURE COMMUNICATIONS

IF15.7

2022-02-0949

OAAI

Attenuation of NLRP3 Inflammasome Activation by Indirubin-Derived PROTAC Targeting HDAC6

靛玉红衍生的PROTAC靶向HDAC6对NLRP3炎性体激活的减弱

ACS CHEMICAL BIOLOGY

IF3.8

2021-12-0343

PREAI

Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs

ACTA NEUROPATHOLOGICA COMMUNICATIONS

IF5.7

2021-04-1428

OAAI

Roles of aryl hydrocarbon receptor in endothelial angiogenic responses

BIOLOGY OF REPRODUCTION

IF3

2020-07-2721

OAAI

Yan Li

个人简介

教育背景

工作经历

荣誉奖项

研究方向